AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Macé, M.
Right arrow Articles by Agut, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macé, M.
Right arrow Articles by Agut, H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2003, p. 3021-3024, Vol. 47, No. 9
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.9.3021-3024.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Real-Time PCR as a Versatile Tool for Investigating the Susceptibility of Human Herpesvirus 6 to Antiviral Agents

Muriel Macé,1 Chaysavanh Manichanh,1,{dagger} Pascale Bonnafous,1 Stéphanie Précigout,1 David Boutolleau,1 Agnès Gautheret-Dejean,1,2 and Henri Agut1*

Laboratoire de Virologie, UPRES EA2387, CERVI, Groupe Hospitalier Pitié-Salpêtrière, 75013 Paris,1 Laboratoire de Microbiologie, Faculté des Sciences Pharmaceutiques et Biologiques, 75006 Paris, France2

Received 27 December 2002/ Returned for modification 10 April 2003/ Accepted 24 June 2003

A quantitative real-time PCR assay was developed for the determination of antiviral drug susceptibility and growth kinetics of human herpesvirus 6. The susceptibility and fitness of a sensitive strain, HST, and its ganciclovir-resistant derivative, GCVR1, were then characterized, leading us to conclude that the mutations of this latter virus did not alter its fitness significantly.


* Corresponding author. Mailing address: Laboratoire de Virologie, CERVI, Groupe Hospitalier Pitié-Salpêtrière, 83 bd. de l'Hôpital, 75651 Paris Cedex 13, France. Phone: 33 1 42 17 74 01. Fax: 33 1 42 17 74 11. E-mail: henri.agut{at}psl.ap-hop-paris.fr.

{dagger} Present address: UEPSD-INRA, Domaine de Vilbert, 78352 Jouy-en-Josas Cedex, France.


Antimicrobial Agents and Chemotherapy, September 2003, p. 3021-3024, Vol. 47, No. 9
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.9.3021-3024.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.